from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2018/-

LFCtreatmentdescriptionclass of inhibitor

1.130

Amikacinug/mL Amikacintranslation

1.692

Cap5-10ug/mL Capreomycintranslation

2.110

Rox10-50 ug/mL Roxithromycintranslation

1.752

SM2-5 ug/mL Streptomycintranslation

1.092

Tet5-10 ug/mL Tetracyclinetranslation

-0.757

Rif0.2-5ug/mL Rifampicintranscription

-1.142

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.143

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.306

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.006

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.260

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.234

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.081

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.345

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.412

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.104

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.002

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.032

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.227

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.258

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.332

KCN5-20 ug/mL Potassium cyaniderespiration

-0.522

NaN30.2-2 mM Sodium aziderespiration

0.187

Nigericin50 uM Nigericinrespiration

0.144

TRC10-150 ug/mL Triclosanrespiration

1.556

TRZ10-25 ug/mL Thioridazinerespiration

1.560

Valinomycin0.5-10 uM Valinomycinrespiration

0.961

ZnSO42 mM ZnSO4respiration

2.107

menadione6-10 ug/mL Menadionerespiration

-0.627

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.275

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.076

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.095

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.919

NRP_1Non-replicating persistence stage 1dosRassociated

0.421

Amp0.2mg/mL AmpicillincellWall

0.059

Cephalexin20-100 ug/mL CephalexincellWall

0.237

Cerulenin0.32-5 ug/mL CerulenincellWall

0.218

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.266

EMB10-20 ug/mL EthambutolcellWall

-0.282

Eta12-40 ug/mL EthionamidecellWall

-0.325

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.407

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.164

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.025

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.253

BZA0.12 mg/mL BenzamidearomaticAmides

-0.113

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.005

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.401

H2O24 mM hydrogen peroxideDNAdamaging

0.171

Levo10 ug/mL LevofloxacinDNAdamaging

0.263

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.906

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.317

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.062

UVUV-irradiationDNAdamaging

-0.194

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.317

Antimycin12.5-50 ug/mL Antimycin A?

-0.866

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.626

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.307

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.306

PA8240.2-2 ug/mL PA-824?

-1.331

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.684

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.054

Verapamil50 uM Verapamil?

-0.388

mercaptoethanol2 mM 2-Mercaptoethanol?

0.043

methoxatin10-20 ug/mL Methoxatin?